
70% Remission for Postpartum Depression? The Psychedelic Breakthrough
30/4/2026
0:00
35:54
Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.
Altri episodi di "Power to the Patients"



Non perdere nemmeno un episodio di “Power to the Patients”. Iscriviti all'app gratuita GetPodcast.








